COPENHAGEN, Denmark — A sperm donor carrying a rare genetic mutation associated with a heightened cancer risk has reportedly fathered at least 197 children across Europe, raising significant health concerns for these families. Investigations indicate that some of these offspring have succumbed to various forms of cancer related to the mutation.

The donor, though considered healthy, possesses a mutation in the TP53 gene, linked to Li-Fraumeni syndrome. This genetic condition significantly increases the likelihood of developing cancer. Unaware of his own genetic condition at the time of donation, he contributed sperm to a single private sperm bank in Denmark, which was then distributed to clinics in 14 different countries.

Earlier reports suggested that this individual had fathered at least 67 children. However, recent developments reveal that the actual number could be nearly triple that figure. The updated information arose from a comprehensive investigation, which included freedom of information requests and interviews with medical professionals and families affected by the condition.

The sperm donor’s contributions were primarily managed by the European Sperm Bank, yet the ramifications extend far beyond Denmark. The lack of consolidated data from all countries involved suggests that the total number of children potentially inheriting the mutation could be even higher. While it remains unclear how many of these children have inherited the mutation, statistics indicate that individuals with Li-Fraumeni syndrome face a daunting 90% chance of developing cancer by the age of 60.

Dr. Edwige Kasper from Rouen University Hospital had previously identified a subset of 67 children during a presentation at an annual genetics conference. Her findings showed that among these children, at least ten had been diagnosed with cancers such as brain tumors and Hodgkin lymphoma, while 13 others carried the mutation without yet developing the disease. These children will face ongoing medical evaluations due to their elevated risk, and there’s a 50% chance they might pass the mutation on to their offspring.

The implications of this case have drawn reactions from cancer genetics experts. Clare Turnbull, a professor at the Institute of Cancer Research in London, emphasized the significant emotional and medical challenges families face when confronted with a diagnosis of Li-Fraumeni syndrome. “The implications are sobering, with high cancer risks throughout life,” she stated.

In light of the situation, Mary Herbert, a reproductive biologist, called for more rigorous genetic screening of sperm donors, emphasizing the urgent need for strict regulations regarding the number of children conceived from a single donor across borders. “It is alarming that one donor could be responsible for nearly 200 children in such a limited geographical area,” she remarked.

Julie Paulli Budtz, a representative from the European Sperm Bank, conveyed that the incident deeply affects both the families and the donor. The organization is committed to ensuring thorough medical assessments of all its donors, advocating for limitations on the number of children conceived using a single donor.

Budtz acknowledged the complexity of existing legislation in this area, calling for standardized regulations to improve transparency and safety for families across Europe. The call for action continues to resonate as the fallout from this unique situation unfolds, prompting a discussion about the responsibilities of sperm banks and the health ramifications of genetic screening in reproductive practices.